Medical Devices Investors & VC Firms
1641 firms in this list, with a median first check of $500K. 343 of them lead rounds. Generated from verified public data and updated continuously.
Capital Medica Ventures
TokyoPre-Seed–Growth
3 people
MedVenture Health
Salt Lake CitySeed–Late Stage
5 people
Summitview Capital
ShanghaiSeries A
5 people
VLX Ventures
JerusalemSeed–Series A$700K – $1M
2 people
Esperante Ventures
LondonSeed–Series A$540K – $5.4M
1 person
Zhejiang Sino Wisdom Investment Co.,Ltd.
HangzhouSeries A–Late Stage
5 people
Longbow Capital LLP
NorwichSeries C–Late Stage$1.3M – $12.7M
2 people
Dow Venture Capital
MidlandSeed–Series A$250K – $5M
1 person
ARAX Capital Partners GmbH
ViennaSeed–Series A$2.2M
4 people
Arcus Ventures
New YorkSeed–Series A
4 people
ePlanet Capital
San JoseSeed–Late Stage
3 people
Wellcome Trust
LondonSeries B–Late Stage
iD Ventures America, LLC
Santa ClaraSeed–Series A$500K – $3M
1 person
Shea Ventures, LLC
WalnutSeed–Series A
1 person
Pivotal bioVenture Partners China
ShanghaiSeed–Series A
4 people
Olympus Innovation Ventures
Seed–Growth
2 people
Omron Ventures
KyotoSeed–Growth
2 people
Alliance Jura-Hongrie Venture Capital Fund Management
BudapestSeries A–Series B$324K – $2.8M
1 person
Alpha Ventures
AthensSeries A–Series B$1.6M – $10.8M
1 person
Cutlass Capital, L.L.C.
BostonSeed–Late Stage$3M – $7M
1 person
FFG Venture Business Partners
FukuokaPre-Seed–Growth
1 person
Kenson Ventures, LLC
Menlo ParkSeed–Late Stage$500K – $3M
1 person
10x Genomics
Pleasanton
4 people
Advantech Capital
Camana BayGrowth
3 people
Related lists
Investors & VC Firms in North America (12832)Investors & VC Firms in United States (11880)Investors & VC Firms in Europe (5830)Investors & VC Firms in Global (4736)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4546)SaaS Investors & VC Firms (4222)Healthtech Investors & VC Firms (4190)Enterprise Software Investors & VC Firms (4099)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.










